Broadfin Capital, LLC - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 35 filers reported holding NOVELION THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$897,000
-13.2%
729,301
-40.7%
0.18%
+36.0%
Q4 2018$1,033,000
-82.1%
1,229,301
-36.9%
0.14%
-84.0%
Q3 2018$5,768,000
-19.6%
1,948,5540.0%0.85%
-24.8%
Q2 2018$7,171,000
+5.1%
1,948,5540.0%1.13%
+6.2%
Q1 2018$6,820,000
+12.2%
1,948,5540.0%1.06%
+6.9%
Q4 2017$6,079,000
-55.6%
1,948,5540.0%0.99%
-50.9%
Q3 2017$13,698,000
-23.8%
1,948,5540.0%2.03%
-7.3%
Q2 2017$17,985,000
-14.1%
1,948,5540.0%2.18%
-13.8%
Q1 2017$20,927,000
+27.5%
1,948,5540.0%2.54%
+39.1%
Q4 2016$16,407,0001,948,5541.82%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,703,420$2,685,0002.61%
Healthcare Value Capital, LLC 1,400,000$1,015,0001.83%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 581,042$421,0000.06%
KNOTT DAVID M 109,135$79,0000.03%
EdgePoint Investment Group Inc. 3,100,931$2,248,0000.02%
Yakira Capital Management, Inc. 36,428$26,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$33,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 84,353$61,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 19,814$14,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders